Archer Pharmaceuticals

Archer Pharmaceuticals, Inc. (Archer) was founded in 2008 and specializes in targeted drug discovery for Alzheimer's disease. Led by CEO and Chief Scientific Officer Michael Mullan, MBBS, Ph.D., and Chief Technology Officer and Chief Scientific Officer Fiona Crawford, Ph.D., Archer was established based on groundbreaking research conducted at the Roskamp Institute in Sarasota, Florida.